Date: January 7, 2014
Source: RIKEN
Summary: PET molecular imaging of the brain reveals that ketamine may act as an antidepressant by boosting serotonin activity in brain areas involved in motivation.
[button url=”https://www.sciencedaily.com/releases/2014/01/140107102442.htm”]Read the Full Story Here[/button]
Leave a Reply